CP10 is a sterile combination peptide formulation containing CJC‑1295 without Drug Affinity Complex (5 mg) and Ipamorelin (5 mg) per 10 mL vial, supplied as a pack of 10 vials. CJC‑1295 (no DAC) is a GHRH analogue used to stimulate pituitary GH release; Ipamorelin is a selective growth‑hormone‑releasing peptide (GHRP) that activates the ghrelin receptor to promote GH secretion. The combined formulation is intended for preclinical and in vitro research into somatotropic‑axis signalling, GH/IGF‑1 pathway modulation, synergistic GHRH+GHRP receptor pharmacology, downstream cellular responses to GH stimulation, and assay development. Exact excipients, vehicle, sterility/endotoxin results, stability, and expiry are batch‑specific and provided on the Certificate of Analysis.Product Usage: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.
